Results 211 to 220 of about 54,066 (258)

Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United States. [PDF]

open access: yesBlood Neoplasia
Mukherjee S   +13 more
europepmc   +1 more source

Albumin does not induce IL-6 release and toll-like receptor activation in vitro: Role of endotoxin contamination and biochemical modifications. [PDF]

open access: yesBBA Adv
Paar M   +8 more
europepmc   +1 more source

Comparative efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia treatment: a meta-analysis of clinical trials and Real-World outcomes. [PDF]

open access: yesAnn Hematol
Sanz-Solas A   +6 more
europepmc   +1 more source

A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemia. [PDF]

open access: yesHemasphere
Jen WY   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy